Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration

Detalhes bibliográficos
Autor(a) principal: Viecili,P.R.
Data de Publicação: 2003
Outros Autores: Pamplona,D., Park,M., Silva,S.R., Ramires,J.A.F., Da Luz,P.L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000600013
Resumo: The concomitant use of angiotensin-converting enzyme inhibitors and aspirin may cause pharmacological antagonism. Hence we examined the effect of aspirin on the neurohormonal function and hemodynamic response to captopril in heart failure patients. Between April 1999 and August 2000, 40 patients were randomized into four equal groups: 1) captopril, 2) aspirin, 3) captopril-aspirin: captopril was given alone on the first day, followed by aspirin on the remaining days, and 4) aspirin-captopril: aspirin was given alone on the first day, followed by captopril on the remaining days. Hemodynamic, norepinephrine and prostaglandin measurements were performed pre- and post-medication for 4 days. Captopril (50 mg) was given orally every 8 h and 300 mg aspirin was given on the first day, and 100 mg/day thereafter. In the captopril group and only on the first day of captopril-aspirin, captopril produced increases in cardiac index (2.1 ± 0.6 to 2.5 ± 0.5 l min-1 m-2, P<0.0001), and reduced peripheral vascular resistance (1980 ± 580 to 1545 ± 506 dyn s-1 cm-5/m², P<0.0001) and pulmonary wedge pressure (20 ± 4 to 15 ± 4 mmHg, P<0.0001). In contrast, aspirin alone or associated with captopril showed no significant hemodynamic changes. Norepinephrine decreased (P<0.02) only in the captopril group. Prostaglandin levels did not differ significantly among groups. Thus, aspirin compromises the short-term hemodynamic and neurohormonal effects of captopril in patients with acute decompensated heart failure.
id ABDC-1_79db69ed2f178ca0ff3308d68b47397e
oai_identifier_str oai:scielo:S0100-879X2003000600013
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administrationPharmacological antagonismAspirinAngiotensin-converting enzyme inhibitorsDecompensated heart failureHemodynamics and neurohormonal changesThe concomitant use of angiotensin-converting enzyme inhibitors and aspirin may cause pharmacological antagonism. Hence we examined the effect of aspirin on the neurohormonal function and hemodynamic response to captopril in heart failure patients. Between April 1999 and August 2000, 40 patients were randomized into four equal groups: 1) captopril, 2) aspirin, 3) captopril-aspirin: captopril was given alone on the first day, followed by aspirin on the remaining days, and 4) aspirin-captopril: aspirin was given alone on the first day, followed by captopril on the remaining days. Hemodynamic, norepinephrine and prostaglandin measurements were performed pre- and post-medication for 4 days. Captopril (50 mg) was given orally every 8 h and 300 mg aspirin was given on the first day, and 100 mg/day thereafter. In the captopril group and only on the first day of captopril-aspirin, captopril produced increases in cardiac index (2.1 ± 0.6 to 2.5 ± 0.5 l min-1 m-2, P<0.0001), and reduced peripheral vascular resistance (1980 ± 580 to 1545 ± 506 dyn s-1 cm-5/m², P<0.0001) and pulmonary wedge pressure (20 ± 4 to 15 ± 4 mmHg, P<0.0001). In contrast, aspirin alone or associated with captopril showed no significant hemodynamic changes. Norepinephrine decreased (P<0.02) only in the captopril group. Prostaglandin levels did not differ significantly among groups. Thus, aspirin compromises the short-term hemodynamic and neurohormonal effects of captopril in patients with acute decompensated heart failure.Associação Brasileira de Divulgação Científica2003-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000600013Brazilian Journal of Medical and Biological Research v.36 n.6 2003reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X2003000600013info:eu-repo/semantics/openAccessViecili,P.R.Pamplona,D.Park,M.Silva,S.R.Ramires,J.A.F.Da Luz,P.L.eng2003-06-03T00:00:00Zoai:scielo:S0100-879X2003000600013Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2003-06-03T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
title Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
spellingShingle Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
Viecili,P.R.
Pharmacological antagonism
Aspirin
Angiotensin-converting enzyme inhibitors
Decompensated heart failure
Hemodynamics and neurohormonal changes
title_short Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
title_full Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
title_fullStr Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
title_full_unstemmed Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
title_sort Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration
author Viecili,P.R.
author_facet Viecili,P.R.
Pamplona,D.
Park,M.
Silva,S.R.
Ramires,J.A.F.
Da Luz,P.L.
author_role author
author2 Pamplona,D.
Park,M.
Silva,S.R.
Ramires,J.A.F.
Da Luz,P.L.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Viecili,P.R.
Pamplona,D.
Park,M.
Silva,S.R.
Ramires,J.A.F.
Da Luz,P.L.
dc.subject.por.fl_str_mv Pharmacological antagonism
Aspirin
Angiotensin-converting enzyme inhibitors
Decompensated heart failure
Hemodynamics and neurohormonal changes
topic Pharmacological antagonism
Aspirin
Angiotensin-converting enzyme inhibitors
Decompensated heart failure
Hemodynamics and neurohormonal changes
description The concomitant use of angiotensin-converting enzyme inhibitors and aspirin may cause pharmacological antagonism. Hence we examined the effect of aspirin on the neurohormonal function and hemodynamic response to captopril in heart failure patients. Between April 1999 and August 2000, 40 patients were randomized into four equal groups: 1) captopril, 2) aspirin, 3) captopril-aspirin: captopril was given alone on the first day, followed by aspirin on the remaining days, and 4) aspirin-captopril: aspirin was given alone on the first day, followed by captopril on the remaining days. Hemodynamic, norepinephrine and prostaglandin measurements were performed pre- and post-medication for 4 days. Captopril (50 mg) was given orally every 8 h and 300 mg aspirin was given on the first day, and 100 mg/day thereafter. In the captopril group and only on the first day of captopril-aspirin, captopril produced increases in cardiac index (2.1 ± 0.6 to 2.5 ± 0.5 l min-1 m-2, P<0.0001), and reduced peripheral vascular resistance (1980 ± 580 to 1545 ± 506 dyn s-1 cm-5/m², P<0.0001) and pulmonary wedge pressure (20 ± 4 to 15 ± 4 mmHg, P<0.0001). In contrast, aspirin alone or associated with captopril showed no significant hemodynamic changes. Norepinephrine decreased (P<0.02) only in the captopril group. Prostaglandin levels did not differ significantly among groups. Thus, aspirin compromises the short-term hemodynamic and neurohormonal effects of captopril in patients with acute decompensated heart failure.
publishDate 2003
dc.date.none.fl_str_mv 2003-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000600013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2003000600013
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X2003000600013
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.36 n.6 2003
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302932191281152